SineFuma Revenue and Competitors
Estimated Revenue & Valuation
- SineFuma's estimated annual revenue is currently $17.3M per year.
- SineFuma's estimated revenue per employee is $278,274
Employee Data
- SineFuma has 62 Employees.
- SineFuma grew their employee count by 5% last year.
SineFuma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $17.3M | 62 | 5% | N/A | N/A |
#2 | $1483.3M | 3728 | 7% | N/A | N/A |
What Is SineFuma?
SineFuma is a company that organizes Stop Smoking Cessation Programs and sells CO-measurement equipment to support Stop Smoking Programs. The Stop Smoking Program that SineFuma offers is based on the Stop Smoking Cessation program used by the National Health Service in the UK. It consists of 7 weekly sessions in which smokers get supervision and support to stop smoking. It is strongly advised that people use either medication of NRT to maintain total abstinence. Further there is focus on relapse prevention and keeping the participants positive and encouraged. In the Netherlands 38% of the participants is still free of smoking after 12 months (of 600+ part.)
keywords:N/A
N/A
Total Funding
62
Number of Employees
$17.3M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SineFuma News
Dit varieert van begeleiding via de eigen rookstoppoli of longarts, de arbo-arts, Sinefuma of via eigen vitaliteitsprogramma's.
Kom bij ons langs: Maandag 9 september vind je de GGD Hart voor Brabant en Sinefuma van 9.00 – 13.00 uur in de centrale hal van het ...
In oktober volgt een tweede editie van de cursus voor medewerkers van het Erasmus MC, gegeven door SineFuma. Aan de cursus is een ...
De campagne werkt samen met onder meer SineFuma, een landelijke organisatie die rokers begeleidt. Anja van Kempen is lovend.
Other Companies in Breda
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 62 | 32% | N/A |
#2 | $26.5M | 63 | -19% | N/A |
#3 | N/A | 64 | 31% | N/A |
#4 | $27.6M | 66 | 6% | N/A |
#5 | N/A | 67 | 8% | N/A |